Profarma Distribuidora de Produtos Farmacêuticos S.A
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It provides pharmaceutical, personal hygiene, and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorpor… Read more
Market Cap & Net Worth: Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3)
Profarma Distribuidora de Produtos Farmacêuticos S.A (SA:PFRM3) has a market capitalization of $163.08 Million (R$993.15 Million) as of March 18, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #22246 globally and #201 in its home market, demonstrating a -8.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Profarma Distribuidora de Produtos Farmacêuticos S.A's stock price R$8.10 by its total outstanding shares 122610573 (122.61 Million).
Profarma Distribuidora de Produtos Farmacêuticos S.A Market Cap History: 2015 to 2026
Profarma Distribuidora de Produtos Farmacêuticos S.A's market capitalization history from 2015 to 2026. Data shows growth from $74.40 Million to $163.08 Million (5.68% CAGR).
Index Memberships
Profarma Distribuidora de Produtos Farmacêuticos S.A is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
SAO PAULO SE IGCX INDEX
IGCX
|
$194.24 Billion | 0.02% | #83 of 155 |
Weight: Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Profarma Distribuidora de Produtos Farmacêuticos S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Profarma Distribuidora de Produtos Farmacêuticos S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap is 0.01 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.14x
Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap is 1.14 times its annual earnings
9.21x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $74.40 Million | $3.47 Billion | -$21.18 Million | 0.02x | N/A |
| 2016 | $127.08 Million | $4.08 Billion | -$48.96 Million | 0.03x | N/A |
| 2017 | $115.50 Million | $4.10 Billion | -$112.72 Million | 0.03x | N/A |
| 2018 | $63.68 Million | $4.27 Billion | -$9.73 Million | 0.01x | N/A |
| 2019 | $104.84 Million | $4.80 Billion | $11.98 Million | 0.02x | 8.75x |
| 2020 | $98.85 Million | $5.48 Billion | $52.33 Million | 0.02x | 1.89x |
| 2021 | $100.85 Million | $6.41 Billion | $78.19 Million | 0.02x | 1.29x |
| 2022 | $66.09 Million | $7.82 Billion | $80.87 Million | 0.01x | 0.82x |
| 2023 | $117.97 Million | $8.66 Billion | $70.40 Million | 0.01x | 1.68x |
| 2024 | $130.66 Million | $10.15 Billion | $114.58 Million | 0.01x | 1.14x |
Competitor Companies of PFRM3 by Market Capitalization
Companies near Profarma Distribuidora de Produtos Farmacêuticos S.A in the global market cap rankings as of March 18, 2026.
Key companies related to Profarma Distribuidora de Produtos Farmacêuticos S.A by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Profarma Distribuidora de Produtos Farmacêuticos S.A Historical Marketcap From 2015 to 2026
Between 2015 and today, Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap moved from $74.40 Million to $ 163.08 Million, with a yearly change of 5.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$163.08 Million | -11.28% |
| 2025 | R$183.81 Million | +40.68% |
| 2024 | R$130.66 Million | +10.76% |
| 2023 | R$117.97 Million | +78.48% |
| 2022 | R$66.09 Million | -34.47% |
| 2021 | R$100.85 Million | +2.03% |
| 2020 | R$98.85 Million | -5.72% |
| 2019 | R$104.84 Million | +64.63% |
| 2018 | R$63.68 Million | -44.86% |
| 2017 | R$115.50 Million | -9.12% |
| 2016 | R$127.08 Million | +70.81% |
| 2015 | R$74.40 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Profarma Distribuidora de Produtos Farmacêuticos S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $163.08 Million USD |
| MoneyControl | $163.08 Million USD |
| MarketWatch | $163.08 Million USD |
| marketcap.company | $163.08 Million USD |
| Reuters | $163.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.